Search results

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

Improving aquaculture for food production in Papua New Guinea

View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.

ANSTO recognises the traditional indigenous owners of the land at all its sites and works to contribute to the recognition of the indigenous cultural heritage of Australia.

The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.

The Graduate Institute is part of ANSTO’s Innovation Precinct and links all graduates together to create a network of Australia’s brightest young minds focused on the future.

Using geoarchaeology to reconstruct the history of an ancient Khmer city.

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

Neutron Capture Enhanced Particle Therapy developed at ANSTO.

The Government is safeguarding Australia’s sovereign capability to produce vital nuclear medicines by launching a $30 million project to design a new world-leading manufacturing facility to be built at Lucas Heights in Sydney.

Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape

Hear from our most recent addition to the nandin Innovation Centre, Tomonori Hu, Founder and CEO of Miriad.

New screening method developed to confirm if deuteration improves metabolic stability.